Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAP Block for Pain Control in AAA Repair
NCT02292667Phase 3Unknown
- Sponsor
- CHU de Besançon
- Start
- Jan 2015
- Primary completion
- Dec 2018
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 3 trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain, sponsored by CHU de Besançon. Status: unknown.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02292667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02292667.